(Q35121542)
Statements
1 reference
Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori (English)
1 reference
T Furuta
1 reference
N Shirai
1 reference
K Ohashi
1 reference
T Ishizaki
1 reference
1 March 2003
1 reference
25
1 reference
2
1 reference
131-143
1 reference
Identifiers
1 reference